Bumrungrad International launches comprehensive genomic profiling for cancer treatment

Bumrungrad International Hospital, a private multiple-specialty medical centre founded 1980 in Bangkok, Thailand, announced the launch of FoundationOne CDx, the first broad companion diagnostic assay to be endorsed by the USFDA in 2017.

from News from healthcareitnews.com http://bit.ly/2Lc3Jvr